OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ABBVIE INC. DL-,01/  US00287Y1091  /

Bulgaria
2024-05-10  4:00:00 PM Chg. -0.40 Volume Bid2024-05-10 Ask2024-05-10 Market Capitalization Dividend Y. P/E Ratio
149.08EUR -0.27% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 263.48 bill.EUR - -
GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 05-09 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 05-08 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire 05-08 ArriVent BioPharma Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-07 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-06 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire 05-02 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05-02 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...
GlobeNewswire 04-30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire 04-25 Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
GlobeNewswire 04-25 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire 04-23 Leaders from Fortune 100 Best Companies to Work For To Share Insights at For All Summit May 7-9
GlobeNewswire 04-22 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 04-22 Anthos Therapeutics Announces Appointment of Bill Meury as CEO
GlobeNewswire 04-19 NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes a...